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Abstract
Background: Many older people presenting to Acute Medical Units (AMU) are discharged after only a short stay
(< 72 hours), yet many re-present to hospital or die within 1 year. Comprehensive Geriatric Assessment may
improve patient outcomes for this group.
Method
Participants: Patients aged > 70 years and scoring positive on a risk screening tool (’Identification of Seniors At
Risk’) who are discharged within 72 hours of attending an AMU with a medical crisis, recruited prior to discharge.
Sample size is 400. Carers of participants will also be recruited.
Intervention: Assessment on the AMU and further out-patient management by a specialist physician in geriatric
medicine. Assessment and further management will follow the principles of Comprehensive Geriatric Assessment,
providing advice and support to primary care services.
Design: Multi-centre, individual patient randomised controlled trial comparing intervention with usual care.
Outcome measurement: Follow up is by postal questionnaire 90 days after randomisation, and data will be entered
into the study database by a researcher blind to allocation. The primary outcome is the number of days spent at
home (for those admitted from home), or days spent in the same care home (if admitted from a care home).
Secondary outcomes include mortality, institutionalisation, health and social care resource use, and scaled outcome
measures, including quality of life, disability, mental well-being. Carer strain and well being will also be measured at
90 days.
Analyses: Comparisons of outcomes and costs, and a cost utility analysis between the intervention and control
groups will be carried out.
Trial Registration: ISRCTN: ISRCTN21800480
Background
Early and rapid hospital triage of patients with medical
crises is undertaken in Acute Medical Units (AMUs) in
the UK. Ninety-eight per cent of UK NHS hospitals
have AMUs [1]. Many patients in AMUs have a very
short length of stay (< 1-2 days) [2]. At least 10% of all
attendees will be frail older people, identified by the pre-
sence of one or more geriatric syndromes [3,4]. Frail
older people who present with a crisis to an AMU but
who are discharged rapidly have poor outcomes: 58%
subsequently re-present to the AMU and 29% die over
the 12 months from the index presentation [4]. Hospital
facilities are expensive and a hospital stay is usually the
most costly episode in the patient’s experience of care.
Managers and clinicians are therefore under pressure to
reduce avoidable hospital admissions. Despite a multi-
tude of efforts to reduce hospital attendance and admis-
sion, the numbers are increasing year on year [5].
There is a considerable body of evidence supporting the
effectiveness of complex interventions for frail older peo-
ple in general [6], particularly Comprehensive Geriatric
Assessment (CGA) [6,7]. However, delivering CGA in the
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and lack of appropriate expertise are all barriers - and a
recent review of the literature was unable to identify any
trials of CGA being delivered in AMUs [8].
We have clinically piloted a version of CGA suitable
for use in older people presenting to AMUs, “interface
geriatrics”, in which a geriatrician makes a clinical
assessment of older patients being discharged from an
AMU, and plans any necessary aftercare including
further assessment at home and liaison with primary
care, intermediate care and specialist community ser-
vices. This study will evaluate interface geriatrics com-
pared with current management, using a randomised
controlled trial with economic analysis.
Objectives
The objective of the study is to examine if the intervention
increases the number of days spent at home in high risk
older patients discharged from an acute medical unit, over
current management, and whether it is cost effective.
Method
A multicentre randomised controlled trial will be con-
ducted. After informed consent and baseline data have
been collected, participants will be randomised to usual
care or the intervention arm, see Figure 1.
Participants
Patient participants will be patients who have been cared
for on the AMU for less than 72 hours at the point of dis-
charge, at either of two recruiting centres. Participants will
be aged 70 years or over, and will be at high risk of future
health problems as evidenced by a score ≥2/6 on the Iden-
tification of Seniors At Risk (ISAR) tool [9]. Patients
excluded from the study will be: those not resident in the
usual hospital catchment area; those without mental capa-
city to give informed consent and where there is no con-
sultee available; those in whom an exceptional reason is
cited by AMU staff why they should not be recruited (e.g.
dangerous); and participants already participating in
another intervention research project. Figure 2 shows the
recruitment algorithm to be used depending upon the pre-
sence or absence of capacity to consent to the study, and
the presence or absence of a carer.
Carer participants will be those identified as a carer of
a patient participant by the patient participant or from
the patient participant’s clinical records.
Baseline data
Baseline data for patient participants will comprise:
￿ Demographics: age, gender, ethnicity, marital sta-
tus, residential status, education, social & financial
questions
￿ Contacts and follow up information: usual and dis-
charge (if different) address & telephone number,
GP contact details
￿ ISAR score
￿ Health conditions: presenting problems, comorbid-
ities and list of medications
￿ Cognitive function: Folstein MMSE [10]
￿ Personal ADL function: Barthel ADL Index [11]
￿ Health status: EuroQoL EQ5D [12] and ICECAP
[13]
￿ Psychological well-being: GHQ-12 [14]
￿ Active receipt of palliative care services
￿ Resource use: health care (primary, secondary,
intermediate and emergency services) and social
services
Baseline data for carer participants will comprise:
￿ Carer strain: Caregiver Strain Index [15]
￿ Carer specific quality of life: CQLI-R [16]
￿ Health status: EuroQol EQ5D [12]
Interventions
Standard care on the AMUs prior to recruitment for
both the control and intervention groups will comprise
an assessment by a consultant physician and attending
medical team. Some patients will be assessed by mem-
bers of a multidisciplinary team (physiotherapist, occu-
pational therapist, nurse), as deemed appropriate by the
AMU team.
Participants in the control group will receive no addi-
tional intervention over and above usual care after ran-
domisation. Usual care is usually directed by the
patient’s general practitioner, but on some occasions
will also include follow up and investigation by the
acute medical team.
Participants in the intervention group will have an
assessment by a geriatrician, who will also deliver or
involve other agencies in the delivery of whatever after-
care they deem is necessary which may include: a review
of diagnoses; a medication review; further assessment at
home or in a clinic; advance care planning; and liaison
with primary care, intermediate care and specialist
community services. The intervention will commence
immediately prior to discharge whilst on the AMU,
continuing in the community and is largely expected to
be complete within one month of randomisation.
Clinical outcomes
The primary outcome will be “days at home”. This will be
calculated as 90 days from randomisation minus the num-
ber of days in this period each participant is in residential
intermediate care units, in hospital (community hospital,
psychiatric hospital or other acute hospital), in respite care
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continuous outcome takes into account many different
adverse outcomes including death and hospital re-admis-
sion or diversion to other settings as a result of health
needs. This outcome will be ascertained from direct follow
up of the participant, health and social service databases.
Secondary outcomes will comprise:
￿ Death
￿ Institutionalisation
￿ Secondary care contacts (Emergency Department,
AMU admissions, clinics)
￿ Personal Activities of Daily Living (Barthel ADL
Index) [11]
￿ Self-reported falls over previous 90 days
￿ Psychological well-being (General Health Ques-
tionnaire, GHQ-12 [14])
￿ Health status (EQ5D [12] & ICECAP [18])
￿ Resource use and associated costs
￿ Carer strain: Caregiver Strain Index [15]
￿ Generic quality of life: EuroQol - EQ5D [12]
￿ Carer specific quality of life: CQLI-R [16]
Outcome measures will be collected by post, by phone
or in person if necessary by a trained researcher not
involved in the recruitment process and blind to allocation.
Resource use
Costs will be estimated for each patient participant
based upon health and social service resource use. Table
 
Control =  
usual care 
Recruit patient and carer 
participants 
Random allocation 
Intervention =  
usual care  
plus  
interface geriatrician 
Outcome ascertainment at 90 days 
Baseline data 
Staff identify suitable 
patients 
Researcher confirms 
eligibility 
AMU 
Figure 1 Overall study outline of a comprehensive geriatric assessment intervention randomised controlled trial. This illustrates the
processes involved in a randomised controlled trial comparing comprehensive geriatrician assessment and intervention over current
management for high risk older patients discharged from an acute medical unit.
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they will be determined, and what unit cost will be
applied to them.
The cost of the interface geriatrician will be derived
from a time log, kept by the participating geriatricians,
of time spent on direct patient care activities (face to
face contact and any other patient-related activities).
Additional information on resource use will be collected
on all participants in both arms (Table 1).
Sample size
The primary outcome is the number of days spent at
home in the 90 days after randomisation. Pilot data in
a similar population demonstrated the mean number
of days spent at home at 90 days was 63 with a stan-
dard deviation of 23 days. Using these data, a sample
size of 200 in each group will have 90% power to
detect a difference in the mean number of days at
home of 7.5 days between the two groups (control
group mean of 63 days and intervention group mean
of 70.5 days) using a two-group t-test with a 5% signif-
icance level.
As days at home accounts for loss to follow up from
events such as death, we will only need to slightly over-
recruit to account for participants who withdraw com-
pletely for from the study (< 5% based on recruitment
to date). Accordingly we aim to recruit up to 420 indivi-
duals overall.
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Figure 2 Recruitment algorithm of a comprehensive geriatric assessment intervention randomised controlled trial. This figure illustrates
the recruitment algorithm to be used depending upon the presence or absence of capacity to consent to the study, and the presence or
absence of a carer.
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Participants will be randomly allocated using a 1:1 ratio
to either the control group or to the intervention group.
Randomisation will be stratified by centre.
Sequence generation
A computer generated pseudo-random list using ran-
dom permuted blocks of randomly varying size will be
used. Access to the sequence will be confined to the
Nottingham Clinical Trials Support Unit (CTSU) Data
Manager.
Implementation
The randomisation sequence will be created by the Not-
tingham CTSU http://ctu.nottingham.ac.uk/ctu in accor-
dance with their standard operating procedures and held
on a secure server. Investigators will access the treatment
allocation for each subject by means of a remote, inter-
net-based randomisation system developed and main-
tained by the Nottingham CTSU. The sequence of
treatment allocations will be concealed from the
researchers collecting the outcome data and the statisti-
cian until statistical analyses are complete.
Blinding
It is not possible to blind participants to the interven-
tion in this study, but outcomes will be collected by
researchers who are blind to allocation and all analyses
will be carried out blind to allocation.
Statistical methods
Descriptive statistics
Continuous data that are approximately normally dis-
tributed will be summarised in terms of the mean, stan-
dard deviation; minimum, maximum and number of
observations. Skewed data will be presented in terms of
the median, lower and upper quartiles, minimum, maxi-
mum and number of observations. Categorical data will
be summarised in terms of frequency counts and per-
centages. There will be no test of statistical differences
or confidence intervals for differences between the inter-
vention and control groups on any baseline variable,
however analyses will be adjusted for prognostically
important variables to improve the precision of the esti-
mates of the intervention effect.
Univariate and multivariate analysis
The primary analysis will be based on the intention to
treat principle, and will compare the primary outcome
(days at home) between the two groups either using a
two-sided t-test or a Mann-Whitney U test if the
assumptions for the t-test are not satisfied, stratified by
centre. We will use data from our recently completed
cohort study (Acute Medicine Outcome Study) to
Table 1 Summary of resource use data to be collected
Parameters Source Unit costs
Baseline primary care resource use per week:
home visit (community matron, specialist nurse, district nurse), attendance at
day care centre, out-of-hours services
Clinical records via GP systems* NHS and PSSRU
reference costs
Baseline personal social services per week: home help, cleaner, private carer,
community care assistant
Patient/carer participant report
Index intervention resource use: length of stay and key interventions. In situ data collection (clinical records or
equivalent hospital systems)*
Follow up secondary care resource use: clinic appointments and category of
appointment;
inpatient days and category of admission;
A&E visits
attendance at day hospital
In situ data collection (clinical records or
equivalent hospital systems)*
Follow up use of emergency services
Paramedic and non-paramedic attended
Clinical records via ambulance service systems*
Follow up primary care resource use:
GP appointments;
home visit (community matron, district nurse, specialist nurse),
attendance at day care centre
out-of-hours services
admission to care home^
Clinical records via GP systems*
Follow up mental health resource use:
CPN visits
Mental health admissions
Clinical records via mental health trust
systems*
Follow up intermediate care resource use per week:
Home visits
Admissions
Clinical records via intermediate care systems*
Personal social services:
home help, cleaner, private carer, community care assistant
Social services records and patient/carer
participant report
*Queries will be generated for the different data systems, to extract patient participant-based activity from baseline to the end of the follow-up period.
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tion, constrained to take values between 0 and 90 days,
to determine the most appropriate statistical model for
the adjusted analysis. We will also use data from the
cohort study to identify prognostically important vari-
ables for days at home in advance of the analysis of the
randomised controlled trial. The intervention effect
parameter will be presented as an estimate with 95%
confidence interval.
We will also carry out a per-protocol efficacy analysis,
looking at those patients who actually received the
intervention.
All continuous secondary outcomes will be analysed
using linear regression models, while logistic regression
and Poisson regression models will be used for dichoto-
mous and count data, respectively. Mortality will be ana-
lysed using Cox proportional hazards regression. All
adjusted analyses will include centre in the model and
other baseline variables used in these models will be
specified in advance of the analysis based on the results
of our prior cohort study. All statistical tests will be
two-sided and performed using a 5% significance level
with no adjustment for multiplicity.
We anticipate a greater recognition of the need for
palliative care services in this population and will test
for interaction between the intervention and terminal
care status. If interaction is present, the results will pre-
sented as sub-group analyses. Other pre-specified sub-
group analyses will be carried out according to the ISAR
score, residency at baseline (care home vs. no care
home) and cognition (MMSE ≤27), as these are prog-
nostically important baseline indicators of adverse
outcomes.
Economic analyses
Costs will be constructed from the perspective of the
NHS and personal social services (PSS). 90 days of
resource data will be collected for each patient partici-
pant. Costs will be estimated for each patient participant
in the study. The costs will be calculated as resource use
multiplied by the unit cost of the specific resource.
Health and social care resource use data will be valued
using published unit cost data [19].
A cost-effectiveness analysis comparing specialist ger-
iatric assessment, intervention and community-based
follow-up following on from an acute admission to stan-
dard care will be carried out. Benefits to the patient par-
ticipant will be measured with Quality-Adjusted Life
Years (QALYs), which will be generated using EQ5D
data, assuming homogeneity across treatment groups in
any insensitivity of the EQ5D to our patient participants.
The time horizon of the economic analysis will incorpo-
rate the lifetime of the cohort, through extrapolation
of quality-adjusted survival from the end of the
intervention period. These will be combined with cost
data to generate incremental cost effectiveness ratios
and Incremental Net Benefit (INB) statistics [20].
No discounting of intervention costs will be necessary
as the intervention period is less than 12 months.
QALYs will be discounted at 3.5%. Incremental cost-
effectiveness analysis will be undertaken in the absence
of convincing dominance by any treatment alternative.
Probabilistic sensitivity analyses and cost-effectiveness
acceptability curves will used to assess the risks posed
by uncertainty in the estimated incremental net benefit
statistics. Value of information and value of distribu-
tional information analyses will also be undertaken if
appropriate.
Procedures for missing, unused and spurious data
If there is less than 5% missing data we will use the
complete dataset but where there is more than 5% miss-
ing data our preferred method will be multiple imputa-
tion. We will use the multiple imputation procedures in
Stata to impute missing values, including all baseline
variables. We will then combine the results using
Rubin’s rules [21] for multiply imputed data.
Additionally we will assess the baseline characteristics
of those who have dropped out or with large amounts
of missing data in order to see if there is any differential
loss to follow up which may result in bias.
Where extreme outliers are identified during model
checking, sensitivity analyses will be carried out includ-
ing and excluding the extreme outliers in order to test
the robustness of the findings.
Ethical approval
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